UBC (United BioSource) partners with biopharma to modernize evidence development, pharmacovigilance, and patient access for specialty therapies. The company connects therapies to patients by delivering customized solutions in access, safety, and evidence generation, leveraging real-world data and advanced analytics. Headquartered in the United States, UBC focuses on ensuring therapies are safe, effective, and accessible throughout the patient journey. It serves biopharma sponsors across risk management, evidence generation, and patient access pathways to accelerate patient outcomes.